Publications search

Found 37769 matches. Displaying 231-240
Charlson ME, Mittleman I, Ramos R, Cassells A, Lin T, Eggleston A, Wells MT, ...
Show All Authors

Preventing "tipping points" in high comorbidity patients: A lifeline from hea...

CONTEMPORARY CLINICAL TRIALS 2025 MAY; 152(?):? Article 107865
Background: This paper describes an innovative cluster randomized controlled trial design to evaluate the comparative effectiveness of two approaches to preventing significant destabilization, leading to unplanned hospitalization and increased disability for patients with high comorbidity, that is, multiple chronic diseases defined by an enhanced Charlson Comorbidity Index >= 4. Methods: A total of 1974 patients were randomized in four waves at each of the sixteen Federally Qualified Health Centers (FQHCs) in four health systems -two in New York and two in Chicago. The two interventions compared 1) Patient-Centered Medical Home (PCMH) as implemented by the FQHCs (usual care control); or 2) PCMH plus a coaching intervention delivered by Health Coaches (experimental) helping patients identify life goals to encourage self-management enhanced by a positive affect/self-affirmation strategy. The two primary patient-centered clinical outcomes are 1) Unplanned hospitalizations; and 2) Within-patient changes in quality of life and disability, as measured by the World Health Organization Disability Assessment Scale 2 (WHODAS 2.0). The hypotheses are: 1) intervention patients will have a 5 % relative reduction in unplanned hospitalizations as compared to control patients; and 2) reduced disability measured by WHODAS2.0; 3) destabilization or 'tipping points' leading to hospitalization will be more often triggered by psychosocial issues than by medical Issues. Conclusion: This cluster RCT has the potential to transform the care for patients with high comorbidity by helping motivate patients to engage in self-management and to successfully navigate the barriers, challenges, and stresses leading to destabilization, hospitalization, and increased disability. ClinicalTrials.gov registration number: NCT04176510
Rosenthal JT, Hafferty FW, Kulasegaram K, Wendland CL, Taylor JS
Show All Authors

Artificial Intelligence Meets Holistic Review: Promises and Pitfalls of Autom...

ACADEMIC MEDICINE 2025 MAY; 100(5):541-546
Holistic review has been widely adopted in medical education as a means of promoting equity in the application process and diversity in the medical workforce. Artificial intelligence (AI) is a rapidly emerging technology already having an impact on the medical school and residency application process as students and faculty alike increasingly turn to AI tools to automate some steps in the preparation and evaluation of application materials. While AI may have the potential to improve the holistic admissions process by increasing efficiency and adding some measure of standardization among reviewers, the authors caution that this promise does not come without certain pitfalls. AI models may introduce new sources of bias and amplify existing ones, which, when combined with a lack of transparency regarding their use in the admissions process, may perpetuate the very inequities that holistic review seeks to minimize. The authors call for the medical education community to establish clear regulations to govern the acceptable use of AI in the admissions process and for a principled adoption of AI tools in a way that is sustainable for applicants and reviewers in the future.
Muñoz-Hernández H, Xu YX, Camardiel AP, Zhang D, Xue A, Aher A, Walker E, Mar...
Show All Authors

Structure of the microtubule-anchoring factor NEDD1 bound to the γ-tubulin ri...

JOURNAL OF CELL BIOLOGY 2025 MAY 21; 224(8):? Article e202410206
The gamma-tubulin ring complex (gamma-TuRC) is an essential multiprotein assembly that provides a template for microtubule nucleation. The gamma-TuRC is recruited to microtubule-organizing centers (MTOCs) by the evolutionarily conserved attachment factor NEDD1. However, the structural basis of the NEDD1-gamma-TuRC interaction is not known. Here, we report cryo-EM structures of NEDD1 bound to the human gamma-TuRC in the absence or presence of the activating factor CDK5RAP2. We found that the C-terminus of NEDD1 forms a tetrameric alpha-helical assembly that contacts the lumen of the gamma-TuRC cone and orients its microtubule-binding domain away from the complex. The structure of the gamma-TuRC simultaneously bound to NEDD1 and CDK5RAP2 reveals that both factors can associate with the "open" conformation of the complex. Our results show that NEDD1 does not induce substantial conformational changes in the gamma-TuRC but suggest that anchoring of gamma-TuRC-capped microtubules by NEDD1 would be structurally compatible with the significant conformational changes experienced by the gamma-TuRC during microtubule nucleation.
Lynn CW, Yu QW, Pang RC, Palmer SE, Bialek W
Show All Authors

Exact minimax entropy models of large-scale neuronal activity

PHYSICAL REVIEW E 2025 MAY 19; 111(5):? Article 054411
In the brain, fine-scale correlations combine to produce macroscopic patterns of activity. However, as experiments record from larger and larger populations, we approach a fundamental bottleneck: the number of correlations one would like to include in a model grows larger than the available data. In this undersampled regime, one must focus on a sparse subset of correlations; the optimal choice contains the maximum information about patterns of activity or, equivalently, minimizes the entropy of the inferred maximum entropy model. Applying this "minimax entropy" principle is generally intractable, but here we present an exact and scalable solution for pairwise correlations that combine to form a tree (a network without loops). Applying our method to over 1000 neurons in the mouse hippocampus, we find that the optimal tree of correlations reduces our uncertainty about the population activity by 14% (over 50 times more than a random tree). Despite containing only 0.1% of all pairwise correlations, this minimax entropy model accurately predicts the observed large-scale synchrony in neural activity and becomes even more accurate as the population grows. The inferred Ising model is almost entirely ferromagnetic (with positive interactions) and exhibits signatures of thermodynamic criticality. Together, these results suggest that a large amount of information may be compressed into a small number of correlations between neurons, and provide the tools for identifying the most important correlations in other complex living systems.
Simoes-Pires EN, Torrente D, Singh P, Strickland S, Norris EH
Show All Authors

Synergistic effects of the Aβ/fibrinogen complex on synaptotoxicity, neuroinf...

ALZHEIMERS & DEMENTIA 2025 MAY; 21(5):? Article e70119
INTRODUCTION: Alzheimer's disease (AD) is characterized by amyloid-beta (A beta), hyperphosphorylated tau, chronic neuroinflammation, blood-brain barrier (BBB) damage, and synaptic dysfunction, leading to neuronal loss and cognitive deficits. Vascular proteins, including fibrinogen, extravasate into the brain, further contributing to damage and inflammation. Fibrinogen's interaction with A beta is well-established, but how this interaction contributes to synaptic dysfunction in AD is unknown. METHODS: Organotypic hippocampal cultures (OHC) were exposed to A beta 42 oligomers, fibrinogen, or A beta 42/fibrinogen complexes. Synaptotoxicity was analyzed by Western blot. A beta 42 oligomers, fibrinogen, or their complexes were intracerebroventricularly injected into mice. Histopathological AD markers, synaptotoxicity, neuroinflammation, and vascular markers were observed by Western blot and immunofluorescence. RESULTS: A beta 42/fibrinogen complexes led to synaptic loss, tau181 phosphorylation, neuroinflammation, and BBB disruption, independent of Mac1/CD11b receptor signaling. Blocking A beta 42/fibrinogen complex formation prevented synaptotoxicity. DISCUSSION: These findings indicate that the A beta 42/fibrinogen complex has a synergistic impact on hippocampal synaptotoxicity and neuroinflammation. Highlights Fibrinogen binds to the central region of A beta, forming a plasmin-resistant complex. The A beta/fibrinogen complex induces synaptotoxicity, inflammation, and BBB disruption. Synaptotoxicity induced by the complex is independent of Mac1 receptor signaling.
Peek J, Bhattacharjee A, Burian J, Hsieh DCC, Hernandez Y, Ternei M, Panfil C...
Show All Authors

Environmental resistome-guided development of resistance-tolerant antibiotics

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2025 MAY 19; 122(21):? Article e2504781122
Failure to anticipate new forms of antibiotic resistance has led to resistance developing rapidly to virtually all antibiotics that have entered clinical use. Many of the most problematic types of resistance originated in the environment, where ancient arms races between antibiotic-producing microbes and their competitors have created vast arsenals of antibiotics and resistance. Seizing on the knowledge that resistance in nature is frequently a harbinger of future clinical resistance, we propose introducing an additional step into the antibiotic development process that exploits the susceptibility of development candidates to environmental resistance as a metric for prioritizing lead compounds and as a roadmap for their structural optimization. Using the antibiotic albicidin as a model, we show how the environmental resistome can guide the development of more resistance-tolerant leads. We used metagenomic surveys to identify resistance vulnerabilities for albicidin and guide the synthesis of analogs that evade the resistance threats. We found that natural albicidin analogs (congeners) were especially enriched in structural features that escape resistance, which inspired our syntheses and provided compelling evidence for the evolution of families of antibiotics in response to resistance in nature. The coupling of metagenomics-based resistance surveillance with structural optimizations of new antibiotics is a broadly applicable approach that is easily integrated into antibiotic development programs to generate compounds that are more resilient in the face of resistance.
Cislo DJ, Pavlopoulos A, Shraiman BI
Show All Authors

"Morphogenetic Action" Principle for 3D Shape Formation by the Growth of Thin...

PHYSICAL REVIEW X 2025 MAY 27; 15(2):? Article 021068
How does growth encode form in developing organisms? Many different spatiotemporal growth profiles may sculpt tissues into the same target 3D shapes, but only specific growth patterns are observed in animal and plant development. In particular, growth profiles may differ in their degree of spatial variation and growth anisotropy; however, the criteria that distinguish observed patterns of growth from other possible alternatives are not understood. Here we exploit the mathematical formalism of quasiconformal transformations to formulate the problem of "growth pattern selection" quantitatively in the context of 3D shape formation by growing 2D epithelial sheets. We propose that nature settles on growth patterns that are the "simplest" in a certain way. Specifically, we demonstrate that growth pattern selection can be formulated as an optimization problem and solved for the trajectories that minimize spatiotemporal variation in areal growth rates and deformation anisotropy. The result is a complete prediction for the growth of the surface, including not only a set of intermediate shapes, but also a prediction for cell displacement along those surfaces in the process of growth. Optimization of growth trajectories for both idealized surfaces and those observed in nature show that relative growth rates can be uniformized at the cost of introducing anisotropy. Minimizing the variation of programmed growth rates can therefore be viewed as a generic mechanism for growth pattern selection and may help us to understand the prevalence of anisotropy in developmental programs.
Liu MH, Blattman SB, Takahashi M, Mandayam N, Jiang WY, Oikonomou P, Tavazoie...
Show All Authors

Conserved genetic basis for microbial colonization of the gut

CELL 2025 MAY 1; 188(9):?
Despite the fundamental importance of gut microbes, the genetic basis of their colonization remains largely unexplored. Here, by applying cross-species genotype-habitat association at the tree-of-life scale, we identify conserved microbial gene modules associated with gut colonization. Across thousands of species, we discovered 79 taxonomically diverse putative colonization factors organized into operonic and non-operonic modules. They include previously characterized colonization pathways such as autoinducer-2 biosynthesis and novel processes including tRNA modification and translation. In vivo functional validation revealed YigZ (IMPACT family) and tRNA hydroxylation protein-P (TrhP) are required for E. coli intestinal colonization. Overexpressing YigZ alone is sufficient to enhance colonization of the poorly colonizing MG1655 E. coli by >100-fold. Moreover, natural allelic variations in YigZ impact inter-strain colonization efficiency. Our findings highlight the power of large-scale comparative genomics in revealing the genetic basis of microbial adaptations. These broadly conserved colonization factors may prove critical for understanding gastrointestinal (GI) dysbiosis and developing therapeutics.
Fan CC, Keeffe JR, Malecek KE, Cohen AA, West AP Jr, Baharani VA, Rorick A, G...
Show All Authors

Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2025 MAY 27; 122(21):? Article e2501637122
Broad immune responses are needed to mitigate viral evolution and escape. To induce antibodies against conserved receptor-binding domain (RBD) regions of SARS-like betacoronavirus (sarbecovirus) spike proteins that recognize SARS-CoV-2 variants of concern and zoonotic sarbecoviruses, we developed mosaic-8b RBD nanoparticles presenting eight sarbecovirus RBDs arranged randomly on a 60-mer nanoparticle. Mosaic-8b immunizations protected animals from challenges from viruses whose RBDs were matched or mismatched to those on nanoparticles. Here, we describe neutralizing mAbs isolated from mosaic-8b-immunized rabbits, some on par with Pemgarda, the only currently FDA-approved therapeutic mAb. Deep mutational scanning, in vitro selection of spike resistance mutations, and single-particle cryo-electron microscopy structures of spike-antibody complexes demonstrated targeting of conserved RBD epitopes. Rabbit mAbs included critical D-gene segment RBD-recognizing features in common with human anti-RBD mAbs, despite rabbit genomes lacking an equivalent human D-gene segment, thus demonstrating that the immune systems of humans and other mammals can utilize different antibody gene segments to arrive at similar modes of antigen recognition. These results suggest that animal models can be used to elicit anti-RBD mAbs with similar properties to those raised in humans, which can then be humanized for therapeutic use, and that mosaic RBD nanoparticle immunization coupled with multiplexed screening represents an efficient way to generate and select broadly cross-reactive therapeutic pan-sarbecovirus and pan-SARS-CoV-2 variant mAbs.
Yoo D, Rhie A, Hebbar P, Antonacci F, Logsdon GA, Solar SJ, Antipov D, Picket...
Show All Authors

Complete sequencing of ape genomes

NATURE 2025 MAY 8; 641(8062):?
The most dynamic and repetitive regions of great ape genomes have traditionally been excluded from comparative studies(1-3). Consequently, our understanding of the evolution of our species is incomplete. Here we present haplotype-resolved reference genomes and comparative analyses of six ape species: chimpanzee, bonobo, gorilla, Bornean orangutan, Sumatran orangutan and siamang. We achieve chromosome-level contiguity with substantial sequence accuracy (<1 error in 2.7 megabases) and completely sequence 215 gapless chromosomes telomere-to-telomere. We resolve challenging regions, such as the major histocompatibility complex and immunoglobulin loci, to provide in-depth evolutionary insights. Comparative analyses enabled investigations of the evolution and diversity of regions previously uncharacterized or incompletely studied without bias from mapping to the human reference genome. Such regions include newly minted gene families in lineage-specific segmental duplications, centromeric DNA, acrocentric chromosomes and subterminal heterochromatin. This resource serves as a comprehensive baseline for future evolutionary studies of humans and our closest living ape relatives.